In this edition of The Post Roll, Thomas George and Scott Willis review the flurry of earnings releases in the cannabis sector. https:\/\/youtu.be\/wsMVmI9q-wY Aphria - Winning in Cannabis 2.0 Aphria had a very solid earnings release, we examine the 2 ways investors can win owning the name and why a hedged (long\/short) strategy is the best risk\/reward. Organigram - Is there a Cash Crunch? The company was once a pot stocks darling, however the latest earnings weren't a thing of beauty. Is the company facing a cash crunch? Aurora - The Pain Trade Continues Aurora has been a disaster for investor, after a 12 for 1 stock reverse split does this mark the end of the 'pain trade'? Fire & Flower Is there More Dilution on the Way?\u00a0 Scott outlines the runway for the stock. Valens - The Preferred Cannabis Oil Play Scott Willis explains why Valens is well positioned relative to Medipharm Labs.